Health Canada Approves Health Claim For Hms 90 / Immunocal
Immunotec Inc. announces that it has received regulatory approval from Health Canada to market
HMS 90 / IMMUNOCAL with the following health claim: “a natural source of the glutathione precursor cysteine for
the maintenance of a strong immune system.”
The Natural Health Products Directorate (NHPD) is Health Canada’s division responsible for the evaluation of the
safety, efficacy and quality of natural health products. It has issued a Natural Product Number (NPN) for
HMS 90 / IMMUNOCAL based on the credibility, strength and quality of evidence provided to support the claim.
Immunotec strongly supports the implementation of the Natural Health Products Regulation. President and Chief
Executive Officer Jim Northrop notes: “The imposition of high standards to ensure the quality, safety and efficacy
of natural products supports Immunotec’s commitment to excellence in product development and manufacturing.
The issuance of this NPN reinforces to consumers and Distributors alike that superb scientific evidence is the
foundation for HMS 90 / IMMUNOCAL. This fact, along with the important associated health claim could have a
significant impact on Immunotec’s business growth.”
Senior Vice-President, Research & Development, Dr. Wulf Dröge, is extremely pleased about this regulatory
approval. “What consumers have known for quite some time has now been formally recognized by the NHPD: the
health benefits of Immunotec’s lead product HMS 90 / IMMUNOCAL for the immune system are based on solid
Natural Health Products must be manufactured, packaged, and labelled in Health Canada-approved facilities
according to current Good Manufacturing Practices to ensure optimal quality of the finished goods. The evaluation
of the efficacy of a specific product allows consumers to make an informed choice when including natural health
products in their wellness regimes.